AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Eagle Pharmaceuticals Inc... (EGRX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.65

null (null%)

At close: Jan 13, 2025, 8:00 PM

2.08

220.00%

Pre-market Oct 03, 2024, 10:10 AM EDT

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	316.61M	171.55M	187.80M	195.89M	213.31M	236.71M	189.48M	66.23M	19.10M	13.68M	2.54M
Cost of Revenue	94.94M	42.18M	45.47M	60.90M	61.92M	57.19M	55.31M	15.65M	11.71M	7.38M	3.17M
Gross Profit	221.67M	129.37M	142.34M	135.00M	151.40M	179.52M	134.18M	50.58M	7.38M	6.30M	-627.00K
Operating Income	80.96M	-2.91M	25.25M	21.82M	36.62M	73.99M	53.35M	2.56M	-18.76M	-8.46M	-19.83M
Interest Income	271.00K	560.00K	562.00K	2.17M	158.00K	91.00K	84.00K	25.00K	31.00K	3.21K	34.00K
Pretax Income	61.43M	-4.55M	22.68M	22.00M	34.04M	72.94M	53.43M	2.57M	-19.27M	-6.95M	-20.16M
Net Income	35.64M	-8.63M	11.99M	14.31M	31.90M	51.94M	81.45M	2.57M	-17.98M	-6.05M	-19.38M
Selling & General & Admin	106.63M	75.32M	78.60M	76.37M	60.51M	71.42M	52.31M	20.16M	9.33M	4.96M	6.40M
Research & Development	34.09M	51.27M	30.79M	36.81M	44.42M	32.61M	30.26M	27.86M	16.82M	9.80M	12.80M
Other Expenses	n/a	-6.24M	-8.26M	700.00K	52.23M	35.22M	32.57M	n/a	35.00K	3.20K	12.00K
Operating Expenses	140.71M	126.60M	109.38M	113.18M	104.93M	104.02M	82.58M	48.02M	26.14M	14.75M	19.20M
Interest Expense	4.04M	1.64M	2.58M	2.69M	2.74M	1.14M	8.00K	11.00K	8.00K	1.40M	309.00K
Selling & Marketing Expenses	8.50M	8.50M	2.70M	2.40M	3.30M	-1.65M	14.78M	4.75M	4.30M	n/a	n/a
Cost & Expenses	235.65M	168.78M	154.85M	174.08M	166.84M	161.21M	137.88M	63.67M	37.86M	22.13M	22.37M
Income Tax	25.79M	4.08M	10.69M	7.68M	2.13M	21.00M	-28.03M	3.00K	-1.29M	-898.70K	-781.00K
Shares Outstanding (Basic)	12.93M	13.05M	13.48M	13.75M	14.77M	15.10M	15.53M	15.25M	9.96M	10.57M	10.57M
Shares Outstanding (Diluted)	13.07M	13.05M	13.77M	14.14M	15.28M	15.91M	16.43M	16.25M	9.96M	10.57M	10.57M
EPS (Basic)	2.76	-0.66	0.89	1.04	2.16	3.44	5.24	0.17	-1.81	-0.57	-1.83
EPS (Diluted)	2.73	-0.66	0.87	1.01	2.09	3.27	4.96	0.16	-1.81	-0.57	-1.83
EBITDA	77.50M	2.77M	30.02M	28.18M	40.44M	77.83M	55.02M	2.70M	-18.76M	-8.41M	-19.61M
Depreciation & Amortization	12.02M	4.81M	4.77M	4.65M	3.67M	3.75M	1.59M	112.00K	104.00K	134.99K	240.00K